# Levosimendan Infusion in Critically Ill Patients With Cardiogenic Shock

> **NCT04917497** · — · COMPLETED · sponsor: **University of Zurich** · enrollment: 43 (actual)

## Conditions studied

- Cardiogenic Shock
- Cardiorenal Syndrome
- Acute Kidney Failure

## Interventions

- **DRUG:** Levosimendan

## Key facts

- **NCT ID:** NCT04917497
- **Lead sponsor:** University of Zurich
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2011-06-30
- **Primary completion:** 2014-04-30
- **Final completion:** 2014-04-30
- **Target enrollment:** 43 (ACTUAL)
- **Last updated:** 2021-06-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04917497

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04917497, "Levosimendan Infusion in Critically Ill Patients With Cardiogenic Shock". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT04917497. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*